Status:
COMPLETED
Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects
Lead Sponsor:
Bausch Health Americas, Inc.
Conditions:
Postoperative Complications
Constipation
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
This is the first multiple-dose experience in humans with MOA-728 in an oral formulation. This study will provide an assessment of the safety, tolerability, and pharmacokinetics (PK) of MOA-728 follow...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy men and women
Exclusion
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00311350
Start Date
March 1 2006
End Date
August 1 2006
Last Update
November 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philadelphia, Pennsylvania, United States, 19148